Vergoeding 2020-2024 voor ATC-subgroep L01XL : Oncolytische cel- en gentherapie
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L01XL02 Talimogeen laherparepvec | 4.073.863 | 3.330.954 | 2.887.122 | 3.522.980 | 3.949.846 |
| L01XL03 Axicabtagen ciloleucel | 12.475.050 | 21.742.230 | 32.078.700 | 27.088.680 | 18.890.790 |
| L01XL04 Tisagenlecleucel | 4.185.600 | 2.441.600 | 2.790.400 | 2.441.600 | 1.395.200 |
| Totaal | 20.734.513 | 27.514.784 | 37.756.222 | 33.053.260 | 24.235.836 |